These Wfs1-Tg2-CreERT2 mice express a tamoxifen-inducible Cre recombinase under the control of the mouse Wfs1 (Wolfram syndrome 1 homolog (human)) promoter/enhancer regions, and may be useful for generating conditional mutations for studying gain or loss of function and/or fate mapping in subgroups of brain tissues (including cortex, hippocampus, and cerebellum).
Ed Lein, Allen Institute for Brain Science
Theresa Zwingman, Allen Institute for Brain Science
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing, Inducible) |
Hemizygous Wfs1-Tg2-CreERT2 mice are viable and fertile. As the Cre-ERT2 fusion gene is under control of the Wfs1 promoter/enhancer regions within the BAC transgene, cre activity is directed to cortex, hippocampus, and cerebellum only following tamoxifen administration. The donating investigators report that Cre recombinase expression for this Wfs1-Tg2-CreERT2 line is more restricted than the Wfs1-Tg3-CreERT2 line (Stock No. Stock No. 009103). The donating investigators may not have assessed expression in tissues other than brain. The Cre-ERT2 fusion protein consists of Cre recombinase fused to a triple mutant form of the human estrogen receptor; which does not bind its natural ligand (17β-estradiol) at physiological concentrations but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, Cre-ERT2 can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered. When Wfs1-Tg2-CreERT2 mice are bred with mice containing a loxP-flanked sequence of interest, tamoxifen-inducible, Cre-mediated recombination will result in deletion of the floxed sequence(s) in the offspring. As such, these Wfs1-Tg2-CreERT2 mice may be useful for generating conditional mutations for studying gain or loss of function and/or fate mapping in subgroups of brain tissues (including cortex, hippocampus, and cerebellum).
For characterization information, see images at the Allen Institute for Brain Science website (Wfs1-Tg2-CreERT2 images).
The 196 kb C57BL/6J mouse bacterial artificial chromosome (BAC) RP23-405O19, containing the entire Wfs1 locus (and other genes), was modified by targeting a CreERT2 fusion gene (Cre-ERT2; Cre recombinase fused to a G400V/M543A/L544A triple mutation of the human estrogen receptor ligand binding domain), SV40 polyA signal, and frt-flanked neomycin cassette to the ATG start site of the Wfs1 locus. The targeted BAC sequences were further modified using FLP recombination to remove the selection cassette and linearized to remove its original vector backbone. The resulting modified BAC was microinjected into embryos from B6C3 mice ((C57BL/6 x C3H)F1 x C57BL/6). Transgenic mice from founder line Wfs1-Tg2-CreERT2 were bred to R26R-EYFP (C57BL/6J congenic background; Stock No. 006148). Next, Wfs1-Tg2-CreERT2 mice were bred with C57BL/6J inbred mice (selectively removing the R26-EYFP allele) for two generations prior to arrival at The Jackson Laboratory. Upon arrival, transgenic mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish this colony.
Expressed Gene | ESR1, estrogen receptor 1, human |
---|---|
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Hemizygous Wfs1-Tg2-CreERT2 mice are viable and fertile. As the Cre-ERT2 fusion gene is under control of the Wfs1 promoter/enhancer regions within the BAC transgene, cre activity is directed to cortex, hippocampus, and cerebellum only following taxomifen administration. |
Allele Name | transgene insertion 2, Ed Lein |
---|---|
Allele Type | Transgenic (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Wfs1-Tg2-CreERT2 |
Gene Symbol and Name | Tg(Wfs1-cre/ERT2)2Aibs, transgene insertion 2, Ed Lein |
Gene Synonym(s) | |
Promoter | Wfs1, wolframin ER transmembrane glycoprotein, mouse, laboratory |
Expressed Gene | ESR1, estrogen receptor 1, human |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Hemizygous Wfs1-Tg2-CreERT2 mice are viable and fertile. As the Cre-ERT2 fusion gene is under control of the Wfs1 promoter/enhancer regions within the BAC transgene, cre activity is directed to cortex, hippocampus, and cerebellum only following taxomifen administration. |
Strain of Origin | (C57BL/6 x C3H)F1 x C57BL/6 |
Chromosome | UN |
Molecular Note | The 196 kb C57BL/6J mouse bacterial artificial chromosome (BAC) RP23-405O19, containing the entire Wsf1 locus (and other genes), was modified by targeting a CreERT2 fusion gene (Cre-ERT2; Cre recombinase fused to a G400V/M543A/L544A triple mutation of the human estrogen receptor ligand binding domain), SV40 polyA signal, and frt-flanked neomycin cassette to the ATG start site of the Wsf1 locus. The targeted BAC sequences were further modified using FLP recombination to remove the selection cassette and linearized to remove its original vector backbone. The resulting modified BAC was microinjected into embryos from B6C3 mice ((C57BL/6 x C3H)F1 X C57BL/6). |
Mutations Made By | Ed Lein, Allen Institute for Brain Science |
When maintaining a live colony, transgenic carrier mice may be bred together, to wildtype (noncarrier) siblings, or to C57BL/6J inbred mice (Stock No. 000664).
When using the Wfs1-Tg2-CreERT2 mouse strain in a publication, please cite the originating article(s) and include JAX stock #009614 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(Wfs1-cre/ERT2)2Aibs |
Frozen Mouse Embryo | B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.